Neurochemical profile of patients with type 1 diabetes measured by 1H-MRS at 4 T

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 5, 2013, Pages 754-759

  Mangia, Silvia ^a   Kumar, Anjali F ^a   Moheet, Amir A ^a   Roberts, Rachel J ^b   Eberly, Lynn E ^b   Seaquist, Elizabeth R ^a   Tkáč, Ivan ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

diabetes; glutamate; MR spectroscopy; neurochemistry; neurotransmitters

Indexed keywords

GLUCOSE; GLUTAMIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BODY MASS; BRAIN NERVE CELL; CONTROLLED STUDY; GRAY MATTER; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NEUROCHEMISTRY; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; ASPARTIC ACID; BRAIN; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; OCCIPITAL LOBE;

EID: 84877581171     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.13     Document Type: Article

References (34)

1. Bischof MG, Brehm A, Bernroider E, Krssak M, Mlynarik V, Krebs M et al. Cerebral glutamate metabolism during hypoglycaemia in healthy and type 1 diabetic humans. Eur J Clin Invest 2006; 36: 164-169.
2. Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 2005; 79: 42-47.
3. Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in healthy humans subjected to recurrent hypoglycemia. J Neurosci Res 2005; 82: 525-530.
4. Heikkila O, Lundbom N, Timonen M, Groop PH, Heikkinen S, Makimattila S. Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain. Diabetologia 2009; 52: 534-540.
5. Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N et al. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry 2009; 66: 878-887.
6. Northam EA, Rankins D, Lin A, Wellard RM, Pell GS, Finch SJ et al. Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 2009; 32: 445-450.
7. Sarac K, Akinci A, Alkan A, Aslan M, Baysal T, Ozcan C. Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus. Neuroradiology 2005; 47: 562-565.
8. Seaquist ER, Damberg GS, Tkac I, Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001; 50: 2203-2209.
9. Seaquist ER, Tkac I, Damberg G, Thomas W, Gruetter R. Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 2005; 54: 1008-1013.
10. Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia 2008; 51: 2088-2092.
11. Geissler A, Frund R, Scholmerich J, Feuerbach S, Zietz B. Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes 2003; 111: 421-427.
12. Haroon E, Watari K, Thomas A, Ajilore O, Mintz J, Elderkin-Thompson V et al. Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients. Psychiatry Res 2009; 171: 10-19.
13. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology 1992; 184: 123-130.
14. Ozsoy E, Doganay S, Dogan M, Alkan A, Firat PG. Evaluation of metabolite changes in visual cortex in diabetic retinopathy by MR-spectroscopy. J Diabetes Complicat 2012; 26: 241-245.
15. Petrou M, Pop-Busui R, Foerster BR, Edden RA, Callaghan BC, Harte SE et al. Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. Academic Radiol 2012; 19: 607-612.
16. Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at ms echo time. Magn Reson Med 1999; 41: 649-656.
17. Tkac I, Gruetter R. Methodology of H-1 NMR spectroscopy of the human brain at very high magnetic fields. Appl Magn Reson 2005; 29: 139-157.
18. Gruetter R. Automatic, localized in vivo adjustment of all first-and secondorder shim coils. Magn Reson Med 1993; 29: 804-811.
19. Gruetter R, Tkac I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med 2000; 43: 319-323.
20. Klose G. Phosphorus-31 studies on lecithin in ethanol solutions. Chem Phys Lipids 1975; 15: 9-14.
21. Barkhuijsen H, Debeer R, Vanormondt D. Improved algorithm for noniterative time-domain model-fitting to exponentially damped magnetic-resonance signals. J Magnet Reson 1987; 73: 553-557.
22. Provencher SW. Estimation of Metabolite Concentrations from Localized in-Vivo Proton Nmr-Spectra. Magnet Reson Med 1993; 30: 672-679.
23. Randall L. Chemical topography of the brain. J Biol Chem 1938; 124: 481-488.
24. Gelman N, Ewing JR, Gorell JM, Spickler EM, Solomon EG. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: relation to estimated iron and water contents. Magn Reson Med 2001; 45: 71-79.
25. Siegel G. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Lippincott-Raven: Philadelphia, PA, 1999.
26. Chang L, Ernst T, Poland RE, Jenden DJ. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 1996; 58: 2049-2056.
27. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magnet Reson Imag 1999; 9: 711-716.
28. Soher BJ, van Zijl PC, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35: 356-363.
29. Wu WE, Gass A, Glodzik L, Babb JS, Hirsch J, Sollberger M et al. Whole brain N-acetylaspartate concentration is conserved throughout normal aging. Neurobiol Aging 2012; 33: 2440-2447.
30. Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, Doraiswamy PM et al. Proton spectroscopy of human brain: effects of age and sex. Progress neuropsychopharmacol Biol Psychiatry 1994; 18: 995-1004.
31. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O. The concentration of N-acetyl aspartate, creatine \+ phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magnet Reson Imag 1993; 11: 799-806.
32. Lim KO, Spielman DM. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 1997; 37: 372-377.
33. Shestov AA, Emir UE, Kumar A, Henry PG, Seaquist ER, Oz G. Simultaneous measurement of glucose transport and utilization in the human brain. Am J Physiol Endocrinol Metab 2011; 301: E1040-E1049.
34. Gruetter R, Ugurbil K, Seaquist ER. Steady-state cerebral glucose concentrations and transport in the human brain. J Neurochem 1998; 70: 397-408.